We are actively tracking the number of publications by the scientific community which reference our structures, whether in the main text, figure captions or supplementary material. Selected articles are manually reviewed. Publications by SSGCID authors are excluded from the manually reviewed list. From our manual curation results, we estimate that the false positive rate might be as high as 50% for some structures.
This list was obtained from Google Scholar searches using an API provided by Christian Kreibich.
| Structure | Year released | #citations |
|---|---|---|
| 6MAO | 2018 | 1 |
| 5DB4 | 2016 | 1 |
| 6MQH | 2018 | 1 |
| 6MTZ | 2018 | 1 |
| 6PTR | 2019 | 1 |
| 6UHW | 2019 | 1 |
| 5WNN | 2017 | 1 |
| 6BN2 | 2018 | 1 |
| 6N1C | 2018 | 1 |
| 6NDS | 2019 | 1 |
| # | PDB | Additional SSGCID structures cited | Link | Title | Year | Citation | Highlighted abstract |
|---|---|---|---|---|---|---|---|
| 1 | 4jnq | - | http://www.mdpi.com/2218-0532/85/1/5 | Natural Products as New Treatment Options for Trichomoniasis: A Molecular Docking Investigation | 2017 | MS Setzer, KG Byler, IV Ogungbe, WN Setzer - Scientia Pharmaceutica, 2017 - mdpi.com | ... Page 8. Sci. Pharm. 2017, 85, 5 8 Figure 4. Overlay of the protein structures of Brucella melitensisTxR, PDB 4JNQ [24] (red ribbon), and the homology model of Trichomonas vaginalis TxR (blueribbon). The co-crystallized ligand is shown as a wireframe structure. ... |
| 2 | 6tz8 | - | https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1011056 | Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond | 2023 | A Rivera, J Heitman- PLoS pathogens, 2023 - journals.plos.org | adapted from Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents ( PDB 6TZ8 ) [3]. The original figure was published |
| 3 | 4qji | - | https://www.sciencedirect.com/science/article/pii/B9780128179031000097 | Natural products encompassing antituberculosis activities | 2020 | A Monga, A Sharma- Studies in Natural Products Chemistry, 2020 - Elsevier | The structure and composition of the cell envelope of M. tuberculosis are distinguished from that of other kinds of prokaryotes S. No. PDB ID, Title, Anti-TB agents 1OY0, Pantothenate kinase, 1e. 4QJI , Phosphopantothenate-cysteine ligase, Phosphopantetheine |
| 4 | 4qhq | - | https://link.springer.com/protocol/10.1007/978-1-4939-8736-8_12 | Navigating Among Known Structures in Protein Space | 2019 | A Narunsky, N Ben-Tal, R Kolodny- Computational Methods in Protein, 2019 - Springer | evolutionary history, with sequences that diverged beyond the point where one can identify their common ancestry; for example, the SCOP fold, CATH Architecture , and ECOD As both neighbors ( pdb 4qhq and pdb 3qwl) have a bound methionine in their PDB structure (Fig |
| 5 | 4k9d | - | https://www.ingentaconnect.com/contentone/ben/cdth/2020/00000015/00000003/art000... | Network-Pharmacology and DFT Based Approach Towards Identification of Leads from Homalomena aromatica for Multi-Target In-Silico Screening on Entamoeba | 2020 | AK Goswami, HK Sharma, N Gogoi- Current Drug, 2020 - ingentaconnect.com | The 3D model of EhGAPDH was predicted based on multiple templates ( PDB IDs: 4O59, 4K9D , 1U8F, 4Z0H, 3V1Y) It uses robust, cross-validated Quantitative Structure Toxicity Relationship (QSTR) models for assessing various measures of toxicity. 3.6 |
| 6 | 3tf6 | - | https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/337776/1/H... | Neural networks for improving drug discovery e fficiency | 2019 | H Hassan Harrirou - 2019 - research-collection.ethz.ch | The PDBBind 2018 general set version contains 19588 biomolecu- lar structures , for which some SMILES or FASTA), or full 3D representations of atom coordinates (ie PDB ), with bonds preferable properties of inputs to most machine-learning algorithms: a fixed-size structure |
| 7 | 7lxy | 7ly2, 7lxz, 7ly3 | https://www.nature.com/articles/s41423-021-00752-2 | Neutralizing antibodies for the prevention and treatment of COVID-19 | 2021 | L Du, Y Yang, X Zhang- Cellular & Molecular Immunology, 2021 - nature.com | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through the receptor-binding domain (RBD) in the S1 subunit of the viral spike (S) protein. ... a–e Cryo-EM structures of the SARS-CoV-2 S trimer bound to NTD-targeting nAbs a S2L28 (PDB 7LXZ), b S2M28 (PDB 7LY2), c S2X333 (PDB 7LXY), d 4-8 (PDB 7LQV), and e 4A8 (PDB 7C2L). |
| 8 | 6bfu | - | https://www.nature.com/articles/s41467-024-49693-0 | Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein | 2024 | W Du, O Debski-Antoniak, D Drabek- Nature, 2024 - nature.com | the antigenic structure of the PDCoV S protein. Through functional and structural characterization The PDB file of PDCoV spike protein ( PDB ID: 6BFU ) and SARS-CoV-2 spike protein ( |
| 9 | 7lxz | 7ly2 | https://www.cell.com/cell-reports/pdf/S2211-1247(21)01401-7.pdf | Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain | 2021 | G Cerutti, Y Guo, P Wang, MS Nair, M Wang, Y Huang- Cell reports, 2021 - cell.com | We produced a structural superposition of all NTD-directed antibodies deposited in the PDB , superposed on NTD Ca atoms, in the context of SARS-CoV-2 spike trimer (Figure 2A). ... Figure S1. Sequence alignment for 5-7 with their corresponding germline genes, Related to Figures 1 and 2. 7LXZ McCallum et al., 2021 |
| 10 | 6ws6 | - | https://www.sciencedirect.com/science/article/pii/S1931312820303620 | Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2 | 2020 | JB Case, PW Rothlauf, RE Chen, Z Liu, H Zhao- Cell host &, 2020 - Elsevier | Using an infectious molecular clone of vesicular stomatitis virus (VSV) expressing eGFP as a marker of infection, we replaced the glycoprotein gene (G) with the spike protein of SARS-CoV-2 (VSV-eGFP-SARS-CoV-2) and developed a high-throughput-imaging-based neutralization assay at biosafety level 2 ... VIR antibody set Pinto et al., 2020 S309 PDB: 6WS6 |